Skip to main content

DLD Asset Management, LP

Position in GILD — Gilead Sciences, Inc.

CIK 1578299 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$252,680
-$502,122 QoQ
Shares Held
2,000
-70.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,775
of 2,265 holders
Holding Since
Jun 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2025
CallValue
$0
CallShares
0
PutValue
$2,749,576
PutShares
24,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

DLD Asset Management, LP holds $728,080 across 3 Drug Manufacturers - General names. GILD ranks #2 (34.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GILD
Gilead Sciences, Inc.
This page
2,000 $252,680

All Filings in GILD

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $252,680 2,000
2025-06-30 $2,749,576 24,800
2025-06-30 $754,802 6,808